Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Neuroscience Letters|May 18, 2005
Intelligence related differences in EEG-bandpowerMichael Doppelmayr, W Klimesch, P Sauseng, et al.Cancer Research|February 1, 1995
Increased p16 levels correlate with pRb alterations in human urothelial cellsT Yeager, W Stadler, C Belair, et al.Journal of Clinical Apheresis|January 1, 1996
Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP)R S Lees, N N Holmes, R W Stadler, et al.Heart Rhythm O2|March 30, 2023
Prolonged PR interval and incidence of atrial fibrillation, heart failure admissions, and mortality in patients with implanted cardiac devices: A real-world surveyHirad Yarmohammadi, Elaine Y Wan, Angelo Biviano, et al.Heart Rhythm|May 19, 2019
Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing: A real-world analysis of 37,450 patients followed by remote monitoringJonathan C Hsu, David Birnie, Robert W Stadler, et al.The European Journal of Neuroscience|December 6, 2005
A shift of visual spatial attention is selectively associated with human EEG alpha activityP Sauseng, W Klimesch, W Stadler, et al.Journal of Cardiovascular Electrophysiology|November 19, 2002
Comparison of electrocardiogram and intrathoracic electrogram signals for detection of ischemic ST segment changes during normal sinus and ventricular paced rhythmsHeinz Theres, Robert W Stadler, Lee Stylos, et al.Oncogene|February 27, 2007
Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profilingK A Furge, M H Tan, K Dykema, et al.Circulation|August 18, 2004
Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization devicePhilip B Adamson, Andrew L Smith, William T Abraham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerD Kaufman, D Raghavan, M Carducci, et al.Pageof 5